Regarding "increase in breast cancer incidence in middle-aged women during the 1990s" (multiple letters)

Annals of Epidemiology

Volumn 15, Issue 6, 2005, Pages 424-425

  Ward, Elizabeth ^a   Jemal, Ahmedin ^a   Thun, Michael ^a   Clarke, Christina A ^b   Prehn, Angela W ^b   Keegan, Theresa H M ^b   Glaser, Sally L ^b   West, Dee W ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b NORTHERN CALIFORNIA CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BREAST CANCER; CALCULATION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CONTROLLED STUDY; FEMALE; GEOGRAPHY; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 20444491901     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2004.09.008     Document Type: Letter

References (7)

1. Anonymous NCI Programs: NCI says cancer rate in Marin matches W. Coast Counties The Cancer Letter 29 2003 4 5
2. A. Witt Prehn C. Clarke B. Topol S. Glaser D. West Increase in breast cancer incidence in middle-aged women during the 1990s Ann Epidemiol 12 2002 476 481
3. C.A. Clarke S.L. Glaser D.W. West R.R. Ereman C.A. Erdmann J.M. Barlow Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990–1999 Breast Cancer Res 4 2002 13
4. Anonymous Faulty estimates led NCI to overstate black-white cancer disparity in Atlanta The Cancer Letter 28 2002 1 5
5. Surveillance, Epidemiology, and End Results (SEER) Program public-use data (1973–2000). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2003, based on the November 2002 submission.
6. Surveillance, Epidemiology, and End Results (SEER) Program public-use data (1973–1999). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; released April 2002, based on the November 2001 submission.
7. H.J. Kim M.P. Fay E.J. Feuer D.N. Midthune Permutation tests for joinpoint regression with applications to cancer rates Stat Med 19 2000 335 351